CA3095473A1 - Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucleotides isoles les codant et leurs utilisations - Google Patents

Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucleotides isoles les codant et leurs utilisations Download PDF

Info

Publication number
CA3095473A1
CA3095473A1 CA3095473A CA3095473A CA3095473A1 CA 3095473 A1 CA3095473 A1 CA 3095473A1 CA 3095473 A CA3095473 A CA 3095473A CA 3095473 A CA3095473 A CA 3095473A CA 3095473 A1 CA3095473 A1 CA 3095473A1
Authority
CA
Canada
Prior art keywords
seq
lysin
polypeptide
activity
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3095473A
Other languages
English (en)
Inventor
Raymond Schuch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Contrafect Corp
Original Assignee
Contrafect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/024912 external-priority patent/WO2019191633A2/fr
Application filed by Contrafect Corp filed Critical Contrafect Corp
Priority claimed from PCT/US2019/047916 external-priority patent/WO2020046747A1/fr
Publication of CA3095473A1 publication Critical patent/CA3095473A1/fr
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention a pour objet des constructions polypeptidiques de lysine-AMP, des polypeptides de lysine isolés et des compositions pharmaceutiques comprenant les polypeptides isolés et/ou les constructions polypeptidiques de lysine-AMP. La présente invention porte également sur des procédés d'utilisation des constructions polypeptidiques de lysine-AMP, sur des polypeptides de lysine isolés et sur des compositions pharmaceutiques, y compris sur des procédés de traitement d'une infection bactérienne d'un organe ou d'un tissu dans laquelle un tensioactif pulmonaire est présent, ou d'infections bactériennes à Gram négatif qui sont associées à un biofilm. De plus, la présente invention se rapporte à des polynucléotides isolés codant les constructions polypeptidiques de lysine-AMP et à des polypeptides de lysine isolés.
CA3095473A 2018-08-23 2019-08-23 Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucleotides isoles les codant et leurs utilisations Pending CA3095473A1 (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201862721969P 2018-08-23 2018-08-23
US62/721,969 2018-08-23
US201862722793P 2018-08-24 2018-08-24
US62/722,793 2018-08-24
USPCT/US2019/024912 2019-03-29
PCT/US2019/024912 WO2019191633A2 (fr) 2018-03-29 2019-03-29 Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucléotides isolés les codant et utilisations correspondantes
US201962849320P 2019-05-17 2019-05-17
US62/849,320 2019-05-17
US62/860,836 2019-06-13
PCT/US2019/047916 WO2020046747A1 (fr) 2018-08-23 2019-08-23 Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucléotides isolés les codant et leurs utilisations

Publications (1)

Publication Number Publication Date
CA3095473A1 true CA3095473A1 (fr) 2020-03-05

Family

ID=72916455

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3095473A Pending CA3095473A1 (fr) 2018-08-23 2019-08-23 Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucleotides isoles les codant et leurs utilisations

Country Status (1)

Country Link
CA (1) CA3095473A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113201050A (zh) * 2020-08-06 2021-08-03 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113201050A (zh) * 2020-08-06 2021-08-03 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用
CN113201050B (zh) * 2020-08-06 2022-07-22 青岛诺安百特生物技术有限公司 一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Similar Documents

Publication Publication Date Title
US20240018192A1 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US20210147498A1 (en) Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in pulmonary surfactant and biofilms
US20220402984A1 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
CA3145990A1 (fr) Polypeptides antimicrobiens, derives de bacteriophage et leur utilisation contre des bacteries gram-negatives et acido-resistantes
US20210324359A1 (en) Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis
US20210330738A1 (en) Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria
US20240181022A1 (en) Amurins lysins, and lysin-antimicrobial peptide (amp) constructs active against gram-negative bacteria
US20220411473A1 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
CA3095473A1 (fr) Constructions polypeptidiques de lysine-peptide antimicrobien (amp), lysines, polynucleotides isoles les codant et leurs utilisations
RU2803121C2 (ru) Полипептидные конструкции лизин-противомикробный пептид (amp), лизины, выделенные полинуклеотиды, кодирующие их, а также варианты их применения

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240816

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240816

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240816

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20240823

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20240823

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20241202

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20241202

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20241202

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241202

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250414

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20250507

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260226